MedPath

Use OF VISHTINDUKA TAILA & VATARI GUGGULU IN GRIDHRASI (SCIATICA)

Phase 3
Not yet recruiting
Conditions
Acquired deformity of musculoskeletal system, unspecified. Ayurveda Condition: GRUDHRASI,
Registration Number
CTRI/2025/04/085932
Lead Sponsor
Department of Agadtantra Evum Vidhi Ayurved Shri NPA Govt Ayurvedic College GE road Raipur
Brief Summary

Ayurveda,an ancient science of life, focuses on maintaining balance for health andlongevity. It divides health principles into eight branches, one of which is *AgadTantra*, dealing with poisons and their treatment. Acharya Charak emphasizedthat poisons, when properly prepared, can become medicines, and conversely,even beneficial medicines can become toxic if used incorrectly. A key part ofAyurveda is understanding *Tridosha*—the balance of Vata, Pitta, andKapha. When these energies are in equilibrium, health prevails; imbalances leadto diseases.

Onesuch disease is *Gridhrasi*, similar to sciatica in modern medicine,characterized by pain, stiffness, and restricted leg movement. It arises fromimbalances in Vata, and in some cases, also Kapha. Sciatica is a commoncondition, caused by issues like poor posture, prolonged sitting, and obesity.It affects many individuals, especially those aged 30-50, and often leads topain, disability, and discomfort.

InAyurveda, treatments such as *Vishtinduka Taila* (derived from *Strychnosnux-vomica*, a poisonous plant) and *Vatari Guggulu* (a herbal remedy)are used for conditions like Gridhrasi. These treatments have properties likepain relief, anti-inflammatory, and nerve tonic effects. However, the toxicpotential of these treatments, especially from the use of Vishtinduka, requirescareful evaluation. Toxicity studies in animals are essential to ensure theirsafety for human use.

Thisstudy aims to evaluate the safety of Vishtinduka Taila through dermal exposurein rats and its clinical effectiveness in treating Gridhrasi. Additionally,Vatari Guggulu’s non-toxic profile has already been established. The ultimategoal is to find an effective, safe treatment for sciatica, using traditionalAyurvedic remedies.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1 Patient between the age of 18-60 years randomly included in study 2 Sex – both male and female 3 Duration of illness – upto 1 year 4 Tenderness of the Sciatic Nerve course 5 Severe pain on squatting 6 Radiating pain, starting from the gluteal region towards the foot 7 Sensory change 8 Non-involvement of Urinary Bladder and Rectum 9 Positive straight leg raising sign.

Exclusion Criteria

1 Age below 20 years and above 70 years 2 Duration of disease more than 1 years 3 Monoplegia 4 Paraplegia 5 Hip joint arthritis 6 TB Spine/Hip 7 Pelvic pathology 8 Traumatic lesion in lumbo – sacral region.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
2 Ruka30 Days
11 Mukhapraseka30 Days
OBJECTIVE PARAMETERS –30 Days
3 Bowstring’s test30 Days
4 Sitting time30 Days
4 Muhurmuhu spandanam30 Days
5 Sakthikshepana nigrahat30 Days
8 Gaurava30 Days
13 Staimitya30 Days
6 Dehasya pravakrata30 Days
9 Aruchi30 Days
12 Bhaktadwesh30 Days
1 Lasegue’s test30 Days
2 Bragard’s test30 Days
5 Standing time30 Days
6 Walking distance30 Days
10 Vahnimardavam (Agnimandhya)30 Days
Subjective parameter30 Days
1 Stambha30 Days
3 Toda30 Days
7 Tandra30 Days
Secondary Outcome Measures
NameTimeMethod
Effectiveness of Vishatinduka Taila & Vatari Guggulu in reducing pain associated with sciatica. Improvements in patient’s quality of life due to reduced pain & increased mobility would be an important outcome30 Days

Trial Locations

Locations (1)

Shri Khudadad Dungaji Govt. Ayurvedic Hospital Raipur Chhattisgarh 492010

🇮🇳

Raipur, CHHATTISGARH, India

Shri Khudadad Dungaji Govt. Ayurvedic Hospital Raipur Chhattisgarh 492010
🇮🇳Raipur, CHHATTISGARH, India
Dr Rupali Yadav
Principal investigator
7974149684
rupaliyadavbsp1995@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.